Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162539 | SCV000212940 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001596980 | SCV000729456 | benign | not provided | 2018-08-09 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001596980 | SCV002010809 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000162539 | SCV002527745 | benign | Hereditary cancer-predisposing syndrome | 2019-12-09 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000602919 | SCV002760506 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000602919 | SCV001741224 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000602919 | SCV001906151 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000602919 | SCV001917801 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000602919 | SCV002035231 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001596980 | SCV002035346 | likely benign | not provided | no assertion criteria provided | clinical testing |